Lippman Marc E

Avg. Two Year Performance

49% Avg. Purchase Return
22% Compound
(2%) Avg. Sale Return
(1%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%5%30%47%49%
Purchase Success Rate3 of 43 of 43 of 44 of 44 of 4
Average Sale Return(< 1%)(< 1%)(2%)(4%)(2%)
Sale Success Rate2 of 72 of 71 of 71 of 70 of 7
Drugs » Biotechnology

Director:

Holdings: 53.74K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--